Jun 26, 2026 04:05PM
Jun 26, 2026 04:05PM
May 27, 2026 01:09AM
May 15, 2026 05:03AM
May 14, 2026 07:00AM
Apr 30, 2026 04:05PM
Mar 19, 2026 02:38PM William Blair on Larimar Therapeutics (LRMR): not without risk but favorable risk/reward
Mar 19, 2026 12:57PM
Mar 19, 2026 07:00AM
Mar 3, 2026 09:30AM
Feb 24, 2026 10:17AM
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM
Jan 5, 2026 06:20AM Leerink Partners Assumes Larimar Therapeutics (LRMR) at Outperform
Nov 5, 2025 07:00AM
Sep 30, 2025 04:05AM
Sep 29, 2025 07:02AM
Sep 29, 2025 07:00AM
Sep 28, 2025 05:00PM
Sep 16, 2025 06:51AM
Aug 19, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Larimar Therapeutics (LRMR)
Aug 14, 2025 02:19PM
Aug 14, 2025 07:00AM
Jul 8, 2025 07:02AM
Jul 8, 2025 07:00AM
Jun 25, 2025 06:07AM
Jun 23, 2025 01:29PM
Jun 23, 2025 08:27AM Leerink Partners Reiterates Outperform Rating on Larimar Therapeutics (LRMR)
Jun 23, 2025 07:01AM
Jun 23, 2025 07:00AM
Jun 20, 2025 04:05PM
Apr 30, 2025 07:00AM
Apr 23, 2025 04:21AM
Mar 25, 2025 12:52PM
Mar 25, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Larimar Therapeutics (LRMR)
Mar 25, 2025 04:24AM
Mar 24, 2025 07:01AM
Mar 24, 2025 07:00AM
Jan 24, 2025 05:18AM
Jan 23, 2025 04:05PM
Dec 17, 2024 06:53AM
Dec 16, 2024 02:38PM Leerink Partners Reiterates Outperform Rating on Larimar Therapeutics (LRMR)
Dec 16, 2024 02:23PM
Dec 16, 2024 01:55PM
Dec 16, 2024 07:02AM
Dec 16, 2024 07:00AM
Nov 19, 2024 06:56AM
Nov 18, 2024 07:02AM
Nov 18, 2024 07:00AM Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
Oct 30, 2024 07:00AM

324,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All